VIM and breast carcinoma: RT-PCR-based analysis of two EMT markers (Vimentin and Zo-1) in MDA-MB-231 breast cancer cell lines treated with Pimozide for 24 hours revealed a significant decrease in the RNA expression of both markers (Figure 4A).